Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
News & Media

Events

  • Berlin, Germany
    3 September 2025 - 6 September 2025
    21st European Burns Association Congress
  • Online
    5:00 pm - 6:00 pm
    3 September 2025
    Webinar 2025: New insights on hemoadsorption in endocarditis
  • Online
    10 September 2025
    Webinar – Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb®
  • Goes, Netherlands
    16 September 2025
    Practitionersdag 2025
  • Kassel, Germany
    17 September 2025 - 19 September 2025
    DGAI der Jahreskongress 2025
  • Online
    5:00 pm - 6:00 pm
    17 September 2025
    Webinar 2025: What’s new in Rhabdomyolysis?
  • Interlaken, Switzerland
    17 September 2025 - 19 September 2025
    Jahrestagung SGI 2025
  • alt="" alt=""
    Amersfoort, Netherlands
    18 September 2025
    NVIC Najaarscongres
  • Online
    3:00 pm - 4:00 pm
    1 October 2025
    Untersuchungs- und Behandlungsmethoden im stationären Bereich
  • Berlin, Germany
    2 October 2025 - 5 October 2025
    Nephrologiekongress 2025
  • Copenhagen, Denmark
    8 October 2025 - 11 October 2025
    EACTS Annual Meeting 2025
  • Munich Skyline Icon for the Congress LIVES In Munich
    Munich, Germany
    25 October 2025 - 29 October 2025
    ESICM 2025
  • Online
    3:00 pm - 4:00 pm
    26 November 2025
    Dokumentation in der Praxis: Fallstricke vermeiden
  • Online
    3:00 pm - 4:00 pm
    11 March 2026
    Der Grundsatz der evidenzbasierten Medizin
  • Online
    3:00 pm - 4:00 pm
    29 April 2026
    Der Einfluss der Ökonomie auf medizinische Entscheidungen
  • Online
    3:00 pm - 4:00 pm
    10 June 2026
    Besonderheiten extrakorporaler Verfahren in der Praxis

Search for Events

CytoSorbents

Voices around the world

world map
Cardiovascular
Dr. Serdar Gunaydin
Ankara, Turkey

One of the most important indications for us to use CytoSorb® in is cardiac surgery, as it has also been cited in many guidelines.

Cardiovascular
Prof. Dr. Yeong-Hoon Choi
Bad Nauheim, Germany

We were able to decrease the need for circulatory supporting medications accordingly, very, very quickly to a tolerable level.

Critical Care
Dr. Voyka Gorjup
Ljubljana, Slovenia

The most prominent clinical effect is the lowering of vasopressors, hemodynamic stability, lowering of interleukins and in those patients who are on vvECMO…